In validating this survival pattern, we further found that the CD61hiCD103+CD8+CD3+ patients with LC also had improved OS prognosis compared to the CD61lo CD103+CD8+CD3+ patients (Fig. 4h). This evidence concerns the gene CD8A and laryngotracheoesophageal cleft.